Making microbes work for mankind - Clever trick or a glimpse of the future for IBD treatment?

Gastroenterology

Volumn 127, Issue 2, 2004, Pages 667-668

  Shanahan, Fergus ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; PROSTAGLANDIN SYNTHASE; TREFOIL PEPTIDE;

AMINO ACID SEQUENCE; CELL PROTECTION; DISEASE SEVERITY; DNA MODIFICATION; EDITORIAL; GASTROINTESTINAL TRACT; IRRITABLE COLON; LACTOBACILLUS DELBRUECKII; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; TRANSGENE;

EID: 4143094837     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.06.029     Document Type: Editorial

References (12)

1. L. Steidler, W. Hans, L. Schotte, S. Neirynck, F. Obermeier, W. Falk, W. Fiers, E. Remaut Treatment of murine colitis by Lactococcus lactis secreting interleukin-10 Science 289 2000 1352 1355
2. K. Brown Genetically modified foods: are they safe Sci Am 284 2001 39 45
3. L. Steidler, K. Robinson, L. Chamberlain, K.M. Schofield, E. Remaut, R.W. Le Page, J.M. Wells Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine Infect Immun 66 1998 3183 3189
4. L.G. Bermudez-Humaran, P. Langella, N.G. Cortes-Perez, A. Gruss, R.S. Tamez-Guerra, S.C. Oliveira, O. Saucedo-Cardenas, R. Montes de Oca-Luna, Y. Le Loir Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production Infect Immun 71 2003 1887 1896
5. C. Beninati, M.R. Oggioni, M. Boccanera, M.R. Spinosa, T. Maggi, S. Conti, W. Magliani, F. De Bernardis, G. Teti, A. Cassone, G. Pozzi, L. Polonelli Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria Nat Biotechnol 18 2000 1060 1064
6. C. Kruger, Y. Hu, Q. Pan, H. Marcotte, A. Hultberg, D. Delwar, P.J. van Dalen, P.H. Pouwels, R.J. Leer, C.G. Kelly, C. van Dollenweerd, J.K. Ma, L. Hammarstrom In situ delivery of passive immunity by lactobacilli producing single-chain antibodies Nat Biotechnol 20 2002 702 706
7. T.L. Chang, C.H. Chang, D.A. Simpson, Q. Xu, P.K. Martin, L.A. Lagenaur, G.K. Schoolnik, D.D. Ho, S.L. Hillier, M. Holodniy, J.A. Lewicki, P.P. Lee Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4 Proc Natl Acad Sci U S A 100 2003 11672 11677
8. L. Steidler, S. Neirynck, N. Huyghebaert, V. Snoeck, A. Vermeire, B. Goddeeris, E. Cox, J.P. Remon, E. Remaut Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 Nat Biotechnol 21 2003 785 789
9. K. Vandenbroucke, W. Hans, J. Van Huysse, S. Neirynck, P. Demetter, E. Remaut, P. Rottiers, L. Steidler Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice Gastroenterology 127 2004 502 513
10. D. Taupin, D.K. Podolsky Trefoil factors initiators of mucosal healing Nat Rev Mol Cell Biol 4 2003 721 734
11. S.S. Poulsen, J. Thulesen, L. Christensen, E. Nexo, L. Thim Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat Gut 45 1999 516 522
12. A. Sinha, J. Nightingale, K.P. West, J. Berlanga-Acosta, R.J. Playford Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis N Engl J Med 349 2003 350 357